|Prognostic significance of autoimmunity during treatment of melanoma with interferon|
H Gogas, J Ioannovich, U Dafni, C Stavropoulou-Giokas, K Frangia, ...
New England Journal of Medicine 354 (7), 709-718, 2006
|Adiponectin and breast cancer risk|
C Mantzoros, E Petridou, N Dessypris, C Chavelas, M Dalamaga, ...
The Journal of Clinical Endocrinology & Metabolism 89 (3), 1102-1107, 2004
|Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials|
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
|Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial|
CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ...
The Lancet 377 (9762), 321-331, 2011
|Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.|
JC Gazet, HT Ford, RC Coombes, JM Bland, R Sutcliffe, J Quilliam, ...
European journal of surgical oncology: the journal of the European Society …, 1994
|Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor–positive breast cancer|
W van de Water, C Markopoulos, CJH van de Velde, C Seynaeve, ...
Jama 307 (6), 590-597, 2012
|Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer|
JC Gazet, HT Ford, JM Bland, RC Coombes, RC Dixon
The Lancet 331 (8587), 679-681, 1988
|Leptin and insulin growth factor I in relation to breast cancer (Greece)|
E Petridou, Y Papadiamantis, C Markopoulos, E Spanos, N Dessypris, ...
Cancer causes & control 11 (5), 383-388, 2000
|Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane …|
JMS Bartlett, CL Brookes, T Robson, CJH van de Velde, LJ Billingham, ...
Journal of clinical oncology 29 (12), 1531, 2011
|Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle|
C Markopoulos, UTA Berger, P Wilson, JC Gazet, RC Coombes
Br Med J (Clin Res Ed) 296 (6633), 1349-1351, 1988
|Impact of breast cancer surgery on the self-esteem and sexual life of female patients|
C Markopoulos, AK Tsaroucha, E Kouskos, D Mantas, Z Antonopoulou, ...
Journal of International Medical Research 37 (1), 182-188, 2009
|Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel|
P Hadji, RE Coleman, C Wilson, TJ Powles, P Clézardin, M Aapro, ...
Annals of oncology 27 (3), 379-390, 2016
|Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized …|
G Fountzilas, D Skarlos, U Dafni, H Gogas, E Briasoulis, D Pectasides, ...
Annals of oncology 16 (11), 1762-1771, 2005
|Heterogeneous HER2 Gene Amplification: Impact on Patient Outcome and a Clinically Relevant Definition|
AI Bartlett, J Starcyznski, T Robson, A MacLellan, FM Campbell, ...
American journal of clinical pathology 136 (2), 266-274, 2011
|Bilateral breast cancer.|
J Gogas, C Markopoulos, P Skandalakis, H Gogas
The American surgeon 59 (11), 733-735, 1993
|Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study|
VS Sabine, C Crozier, CL Brookes, C Drake, T Piper, CJH van de Velde, ...
Journal of Clinical Oncology 32 (27), 2951-2958, 2014
|Expression of alpha-thymosins in human tissues in normal and abnormal growth|
OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ...
Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993
|Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial|
C Markopoulos, E Tzoracoleftherakis, A Polychronis, B Venizelos, U Dafni, ...
Breast cancer research 12 (2), R24, 2010
|The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study|
C Markopoulos, A Polychronis, V Zobolas, G Xepapadakis, ...
Breast cancer research and treatment 93 (1), 61-66, 2005
|Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early …|
SE Jones, C Seynaeve, A Hasenburg, D Rae, J Vannetzel, R Paridaens, ...
Cancer research 69 (2 Supplement), 15, 2009